Tahir Amin Speaks to NDTV About the Recent Victory Against Abbott Laboratories HIV Drug Patent

Priti Radhakrishnan Speaks About the Future of Trade and Access to Medcinines at the Spotlight on the Millennials

I-MAK's Co-Founder, Priti Radhakrishnan, was selected from a group of young visionaries by the King Baudouin Foundation as part of their 'Spotlight on the Millennials' to share her ideas on the future of trade and access to medicines.

I-MAK's Directors at Mayo Clinic's Symposium 'Transform 2010'

I-MAK's directors present on making patents work for patients at the Mayo Clinic's Symposium 'Transform 2010 - Thinking Differently About Healthcare'.

I-MAK's Tahir Amin on Washington Business Tonight Discussing the Case Against Abbott's Drug Kaletra

I-MAK Director, Tahir Amin, interviewed by Washington Business Tonight about Abbott Laboratories patents on the drug Kaletra. 

I-MAK's Priti Radhakrishnan at Pop!Tech

Pop!Tech announces its 2008 Social Innovation Fellows Program, including Priti Radhakrishnan from I-MAK. Pop!Tech Social Innovation Fellows are high potential young leaders with new approaches poised for transformational impact.